Skip to content

A Swedish Internet CBT for Prolonged Grief Disorder: a Three-armed RCT

Efficacy and Mechanisms of Change of Online Cognitive Behavioural Therapy for Prolonged Grief Disorder After Loss: a Three-armed Randomised Control Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06667674
Enrollment
270
Registered
2024-10-31
Start date
2025-04-23
Completion date
2028-07-31
Last updated
2025-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged Grief Disorder

Brief summary

The goal of this clinical trial is to evaluate the effectiveness of internet-delivered Cognitive Behavioral Therapy (iCBT) in reducing symptoms of prolonged grief in adults diagnosed with prolonged grief disorder. The main questions the study aims to answer are: * Does iCBT reduce symptoms of prolonged grief disorder, posttraumatic stress, and depression following the death of a loved one in the short and long term? * What mechanisms contribute to the effectiveness of iCBT in treating prolonged grief disorder? The iCBT intervention will be compared to a waitlist control group and an active control group to see if iCBT reduces symptoms of prolonged grief disorder more effectively than no treatment or a placebo treatment. Participants will: * Be randomly assigned to either the iCBT group, an active control group or a waitlist control group * Complete online assessments of symptom severity, grief cognitions, and level of avoidance before, during and after intervention * Engage in 10 weeks of a therapist-guided online treatment

Detailed description

The death of a loved one can lead to various mental and physical health problems. Previous research has shown that Cognitive Behavioral Therapy (CBT) can be effective in recuding symptoms of prolonged grief. However, most previous studies have had small sample sizes and lacked follow-up assessments over time. The purpose of this project is to conduct a large randomized controlled trial (RCT) to evaluate the effectiveness of internet-delivered cognitive-behavioral therapy (iCBT) in reducing symptoms of prolonged grief, depression, and posttraumatic stress in adults who have lost a loved one. The iCBT treatment will be compared against both an active control condition and a waitlist condition. Participants in the active control condition will receive a simplified version of the iCBT treatment, which is also therapist-led but lacks active CBT components. The waitlist control group will receive the iCBT treatment after 10 weeks. Follow-up assessments will be conducted at 6 and 12 months after treatment completion. The study will also examine potential moderators (such as baseline symptom levels and loss characteristics) and mediators (such as belief in treatment efficacy, changes in negative cognitions and level of avoidance) on treatment effects. This may provide insights into the effectiveness of prolonged grief treatment and factors that influence treatment outcomes. Participants will be recruited through advertisements on social media platforms, and organisations and clinical contacts. Individuals interested in participating in the study register their interest on a website linked to the research project, and complete an initial screening form. Potential participants are contacted by phone to schedule an assessment interview over video, which includes the structured diagnostic interview Mini International Neuropsychiatric Interview (M.I.N.I.). Subsequently, eligible participants are randomized to iCBT, active control, or waitlist control. The participants will be informed that they have been randomly assigned to either a waitlist or one of two grief treatment programs but will not know which of the treatments they are in, and are thus blind at the beginning of the study. The treatment is accessed on a digital platfom. This study is the first of its kind in Sweden to examine the effectiveness of internet-delivered treatment for prolonged grief. Additionally, it is the first trial to assess both short- and long-term effects of iCBT for prolonged grief compared to an active control group.

Interventions

BEHAVIORALiCBT for prolonged grief

Participants will undergo a 10-week internet-delivered, therapist-led cognitive behavioral therapy treatment (iCBT) for prolonged grief, which includes psychoeducation about grief and common grief reactions, exposure, cognitive restructuring and behavioral activation.

BEHAVIORALActive control

Participants will undergo a 10-week internet-delivered, therapist-led treatment, which includes psychoeducation about grief and common grief reactions.

Sponsors

Uppsala University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Active control group, waitlist control group and intervention group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Currently residing in Sweden * Lost a relative or close friend to any cause of death at least six months ago * Suffers from prolonged grief disorder

Exclusion criteria

* Ongoing severe psychiatric problems that may prevent treatment implementation or require more urgent care (e.g., participants with untreated psychotic disorder, untreated bipolar disorder, ongoing substance abuse, elevated suicide risk) * Change in dosage of any medication for mental health issues (e.g., antidepressant medication) in the past four weeks or in the next two months

Design outcomes

Primary

MeasureTime frameDescription
Change (from baseline) in Traumatic Grief Inventory Self Report Plus, TGI-SR+0, 5 and 10 weeks. Follow-up at 6 and 12 months post-treatment.A 22-item, self-rated measure of prolonged grief symptoms. Total score ranges from 22 to 110, where a higher score indicates more symptoms.

Secondary

MeasureTime frameDescription
Change (from baseline) in Depressive and Anxious Avoidance in Prolonged Grief questionnaire, DAAPGQ0, 5 and 10 weeks. Follow-up at 6 and 12 months post-treatment.A 9-item, self-rated measure of avoidance. Total score ranges from 9-72, and a higher score indicates more avoidance
Change (from baseline) in Grief Cognitions Questionniare, GCQ0, 5 and 10 weeks. Follow-up at 6 and 12 months post-treatment.An 18-item, self-rated measure of grief cognitions. Total score ranges from 0-90, and a higher score indicates more grief cognitions
Change (from baseline) in the short version of Traumatic Grief Inventory Self Report Plus, Short version TGI-SR+Weekly assessments between week 0 and week 10, excluding week 5.Five items from TGI-SR+, measuring PGD symptoms. Total score ranges from 5-25, and a higher score indicates more symptoms.
Change (from baseline) in Short Form Posttraumatic stress disorder checklist for DSM-5, Short form PCL-5Weekly assessments between week 0 and week 10, excluding week 5.Four items from PCL-5, measuring PTSD symptoms. Total score ranges from 0-16, and a higher score indicates more symptoms.
Change (from baseline) in Patient Health Questionnaire, PHQ-2Weekly assessments between week 0 and week 10, excluding week 5.Two items from PHQ-9, measuring depression. Total score ranges from 0-6, and a higher score indicates more symptoms.
Change (from baseline) in Posttraumatic stress disorder checklist for DSM-5, PCL-50, 5 and 10 weeks. Follow-up at 6 and 12 months post-treatment.A 20-item, self-rated measure of posttraumatic stress disorder. Total score ranges from 0-80, and a higher score indicates more symptoms
Change (from baseline) in Patient Health Questionnaire, PHQ-90, 5 and 10 weeks. Follow-up at 6 and 12 months post-treatment.A 9-item, self-rated measure of depression. Total score ranges from 0-27, and a higher score indicates more symptoms

Other

MeasureTime frameDescription
Negative effects questionnaireWeek 10Negative effects questionnaire (NEQ; Rozental et al., 2019)
Client Satisfaction Questionnaire Eight, CSQ-8Week 10An 8-item, self-rated measure of participants' treatment experience. Total score ranges from 8-32, where a higher score indicates greater satisfaction with the treatment.
Demographics0 monthsAge, gender, time since loss, marital status, employment status, loss-related variables
Treatment Credibility Scale, TCSWeek 2A 5-item, self-rated measure of participants' view of treatment credibility. Total score ranges from 5-50, and higher scores indicate stronger beliefs in treatment efficacy and credibility.

Countries

Sweden

Contacts

Primary ContactJosefin Sveen, Professor
josefin.sveen@uu.se+46 738 66 70 87

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026